Dapagliflozin, a sodium ‐glucose co‐transporter‐2 inhibitor, slows the progression of renal complications through the suppression of renal inflammation, endoplasmic reticulum stress and apoptosis in prediabetic rats

Diabetes, Obesity and Metabolism, EarlyView.

Source: Diabetes, Obesity and Metabolism - July 17, 2018 Category: Endocrinology Authors: Krit Jaikumkao PhD , Anchalee Pongchaidecha PhD , Nuttawud Chueakula MS , La ‐ongdao Thongnak MS , Keerati Wanchai PhD , Varanuj Chatsudthipong PhD , Nipon Chattipakorn MD , Anusorn Lungkaphin PhD Source Type: research